These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 172182)

  • 1. Letter: Allergic reactions to tetracosactrin.
    Mohr PD
    Br Med J; 1975 Oct; 4(5989):162. PubMed ID: 172182
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: 1-18 Corticotrophin and allergy to tetracosactrin-depot.
    Brombacher PJ; Maesen FP; Gijzen AH
    Lancet; 1975 Feb; 1(7904):456. PubMed ID: 48646
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adverse effects of synthetic ACTH (tetracosactide-Zn)--asthmatic attack and shock-report of 2 cases].
    Kawai M; Maekawa N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1975 Nov; 13(11):663-70. PubMed ID: 176495
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergic reactions to steroids presenting with neurological symptoms.
    Behan PO; Thomas M; Behan WM
    Acta Neurol Scand; 1982 May; 65(5):432-41. PubMed ID: 6287794
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
    Kropp R
    Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen].
    Roldaan AC; de Jong C
    Ned Tijdschr Geneeskd; 1981 Feb; 125(8):321-3. PubMed ID: 6261167
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypersensitivity to tetracosactide].
    Ligumski M; Kletter-Chemo D; Penchas S
    Harefuah; 1977 Feb; 92(4):169-70. PubMed ID: 191336
    [No Abstract]   [Full Text] [Related]  

  • 8. Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema.
    Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():135-8. PubMed ID: 178340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.
    Glass D; Roffe L; Maini RN; Wraith DG; Nuki G
    Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Discussion of a case of dyschromia].
    Nicolay M; Piot V
    Arch Belg Dermatol; 1974; 30(2):99-101. PubMed ID: 4377809
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fatal complication of intravenous administration of synthetic adrenocorticotrophin].
    Müller M; Fehm HL; Homoki J; Teller WM
    Dtsch Med Wochenschr; 1982 Sep; 107(36):1353-6. PubMed ID: 6288339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pancreatitis after therapy with synthetic ACTH.
    Trancoso VN; Ramos JS; Barreiras J; Reis B
    Am J Gastroenterol; 1984 Oct; 79(10):769-72. PubMed ID: 6091442
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of Cortrosyn Depot in dermatology].
    Aussems J
    Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tetracosactide in the treatment of rheumatoid arthritis and gout].
    Usobiaga JL
    Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synacthen retard].
    Ménégol B; Brard M
    Soins; 1985 Apr; (451):I-II. PubMed ID: 3008345
    [No Abstract]   [Full Text] [Related]  

  • 16. [Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide].
    Cret L; David M; Macabéo V; Frédérich A; Jeune M
    Pediatrie; 1976; 31(1):33-48. PubMed ID: 184427
    [No Abstract]   [Full Text] [Related]  

  • 17. Herpes zoster and tetracosactrin.
    Silberman D
    Med J Aust; 1980 Nov; 2(9):518. PubMed ID: 6259503
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)].
    Bordier C; Flechet ML; Thomine E; Lauret P
    Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolic disorders induced by a combination of sodium gamma-hydroxybutyrate and tetracosactide in head-injury patients].
    Béal JL; Freysz M; Honnart D; Wilkening M
    Therapie; 1983; 38(5):569-71. PubMed ID: 6322376
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synacthen depot-induced liver damage in the therapy of secondary generalized epilepsies in childhood].
    John K; Gaida P; Kauf E
    Padiatr Grenzgeb; 1985; 24(5):391-9. PubMed ID: 2999679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.